{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:46:33Z","timestamp":1785527193779,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41375-026-03019-9","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:24:25Z","timestamp":1782480265000},"page":"1820-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications"],"prefix":"10.1038","volume":"40","author":[{"given":"Yuting","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-5290","authenticated-orcid":false,"given":"Yulan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6290-639X","authenticated-orcid":false,"given":"Weihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-4614","authenticated-orcid":false,"given":"Gang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8752-0644","authenticated-orcid":false,"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-812X","authenticated-orcid":false,"given":"Shuhua","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Chinese Workshop of Indolent Lymphomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"3019_CR1","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","volume":"123","author":"A Mart\u00ednez-Trillos","year":"2014","unstructured":"Mart\u00ednez-Trillos A, Pinyol M, Navarro A, Aymerich M, Jares P, Juan M, et al. Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome. Blood. 2014;123:3790\u20136.","journal-title":"Blood"},{"key":"3019_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00351-w","volume":"10","author":"W Shuai","year":"2020","unstructured":"Shuai W, Lin P, Strati P, Patel KP, Routbort MJ, Hu S, et al. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features. Blood Cancer J. 2020;10:86.","journal-title":"Blood Cancer J"},{"key":"3019_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/leu.2016.330","volume":"31","author":"C Baer","year":"2017","unstructured":"Baer C, Dicker F, Kern W, Haferlach T, Haferlach C. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia. Leukemia. 2017;31:1355\u201362.","journal-title":"Leukemia"},{"key":"3019_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/leu.2013.263","volume":"28","author":"S Jeromin","year":"2014","unstructured":"Jeromin S, Weissmann S, Haferlach C, Dicker F, Bayer K, Grossmann V, et al. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia. 2014;28:108\u201317.","journal-title":"Leukemia"},{"key":"3019_CR5","doi-asserted-by":"publisher","first-page":"25455","DOI":"10.18632\/oncotarget.16037","volume":"8","author":"TS Chan","year":"2017","unstructured":"Chan TS, Lee YS, Del Giudice I, Marinelli M, Ilari C, Cafforio L, et al. Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients. Oncotarget. 2017;8:25455\u201368.","journal-title":"Oncotarget"},{"key":"3019_CR6","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41375-021-01124-5","volume":"35","author":"S Yi","year":"2021","unstructured":"Yi S, Yan Y, Jin M, Xiong W, Yu Z, Yu Y, et al. High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia. Leukemia. 2021;35:2412\u20135.","journal-title":"Leukemia"},{"key":"3019_CR7","doi-asserted-by":"crossref","unstructured":"Ahn A, Kim HS, Kim TY, Lee JM, Kang D, Yu H, et al. Genetic and clinical characteristics of Korean chronic lymphocytic leukemia patients with high frequencies of MYD88 mutations. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24043177"},{"key":"3019_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1182\/blood-2015-05-648634","volume":"126","author":"P Baliakas","year":"2015","unstructured":"Baliakas P, Hadzidimitriou A, Agathangelidis A, Rossi D, Sutton LA, Kminkova J, et al. Prognostic relevance of MYD88 mutations in CLL: the jury is still out. Blood. 2015;126:1043\u20134.","journal-title":"Blood"},{"key":"3019_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0014-y","volume":"7","author":"SC Qin","year":"2017","unstructured":"Qin SC, Xia Y, Miao Y, Zhu HY, Wu JZ, Fan L, et al. MYD88 mutations predict unfavorable prognosis in chronic lymphocytic leukemia patients with mutated IGHV gene. Blood Cancer J. 2017;7:651.","journal-title":"Blood Cancer J"},{"key":"3019_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/bjh.15714","volume":"184","author":"MR Improgo","year":"2019","unstructured":"Improgo MR, Tesar B, Klitgaard JL, Magori-Cohen R, Yu L, Kasar S, et al. MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL. Br J Haematol. 2019;184:925\u201336.","journal-title":"Br J Haematol"},{"key":"3019_CR11","doi-asserted-by":"crossref","unstructured":"Mu Y, Fan X, Chen T, Meng Y, Lin J, Yuan J, et al. MYD88-mutated chronic lymphocytic leukaemia\/small lymphocytic lymphoma as a distinctive molecular subgroup is associated with atypical immunophenotypes in Chinese patients. J Clin Med. 2023;12.","DOI":"10.3390\/jcm12072667"},{"key":"3019_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3324\/haematol.2016.141812","volume":"101","author":"LA Sutton","year":"2016","unstructured":"Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, et al. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica. 2016;101:959\u201367.","journal-title":"Haematologica"},{"key":"3019_CR13","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood.2020007039","volume":"137","author":"A Agathangelidis","year":"2021","unstructured":"Agathangelidis A, Chatzidimitriou A, Gemenetzi K, Giudicelli V, Karypidou M, Plevova K, et al. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood. 2021;137:1365\u201376.","journal-title":"Blood"},{"key":"3019_CR14","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/1078-0432.CCR-15-1525","volume":"22","author":"J Rovira","year":"2016","unstructured":"Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L, et al. MYD88 L265P mutations, but no other variants, identify a subpopulation of DLBCL patients of activated B-cell origin, extranodal involvement, and poor outcome. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:2755\u201364.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3019_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa1817073","volume":"381","author":"TD Shanafelt","year":"2019","unstructured":"Shanafelt TD, Wang XV, Kay NE, Hanson CA, O\u2019Brien S, Barrientos J, et al. Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia. N Engl J Med. 2019;381:432\u201343.","journal-title":"N Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03019-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:09:56Z","timestamp":1785521396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03019-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3019"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03019-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the Ethics Committee of the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (approval\/reference number: IIT2021030-EC-1) and conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients before enrollment.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}